Tekla Life Sciences Investors (HQL) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 2.13M | 1.25M | 42.54K | 5.05M | 13.64K | 623.92K | 3.39M | 144.66K | 5.57K | 73.9K | 4.46M | 5.09M |
| Cash & Short-Term Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Cash Only | - | - | - | - | - | - | - | - | - | - | - | - |
| Short-Term Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Accounts Receivable | - | - | - | - | - | - | - | - | - | - | - | - |
| Days Sales Outstanding | - | 8.93 | - | 7.8 | 15.05 | 7.83 | 14.55 | 0.43 | 0.02 | - | 17.04 | 275.75 |
| Inventory | - | - | - | - | - | - | - | - | - | - | - | - |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 0 | 0 | -18.55M | 0 | 2.65M | 11.09M | 13.94M | 8.46M | 1.05M | 4.97M | 12.63M | 12.03M |
| Total Non-Current Assets | 561.1M | 514.13M | 411.3M | 397.53M | 432.64M | 414.08M | 444.99M | 534.01M | 503.2M | 483.97M | 397.21M | 381.47M |
| Property, Plant & Equipment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Fixed Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 561.04M | 505.7M | 392.76M | 397.53M | 432.64M | 414.08M | 444.99M | 534.01M | 503.2M | 483.97M | 397.21M | 381.47M |
| Other Non-Current Assets | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Assets | 563.23M | 515.38M | 411.34M | 402.6M | 432.69M | 414.73M | 448.41M | 534.19M | 503.33M | 484.17M | 402.08M | 386.98M |
| Asset Turnover | 0.09x | 0.03x | 0.04x | 0.07x | 0.00x | 0.05x | 0.02x | 0.03x | 0.06x | 0.04x | 0.06x | 0.00x |
| Asset Growth % | 36.92% | - | - | -2.92% | -3.51% | -22.36% | -10.91% | 10.33% | 25.18% | 25.11% | -5.83% | -19.12% |
| Total Current Liabilities | 0 | 720.9K | 15.08M | 0 | 10.04M | 5.1M | 3.54M | 10.75M | 44.08K | 581.24K | 585.19K | 2.82M |
| Accounts Payable | 0 | 720.9K | 6.54M | 0 | 12.82K | 5.1M | 3.54M | 150.34K | 44.08K | 73.9K | 0 | 2.82M |
| Days Payables Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12.09K | 0 | 0 |
| Deferred Revenue (Current) | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Liabilities | 0 | 0 | 0 | 0 | -10.04M | -5.1M | -3.54M | -9.4M | -44.08K | -595.18K | -585.19K | -2.82M |
| Current Ratio | - | 1.74x | 0.00x | - | 0.00x | 0.12x | 0.96x | 0.01x | 0.13x | 0.13x | 7.62x | 1.80x |
| Quick Ratio | - | 1.74x | 0.00x | - | 0.00x | 0.12x | 0.96x | 0.01x | 0.13x | 0.13x | 7.62x | 1.80x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 2.4M | 1.01M | 324.37K | 666.96K | 10.04M | 5.1M | 3.54M | 9.4M | 649.63K | 569.15K | 585.19K | 3.33M |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | - | - | - | - | - | - | - | - | - | - | - | - |
| Deferred Tax Liabilities | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Non-Current Liabilities | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Liabilities | 2.4M | 1.73M | 15.4M | 666.96K | 10.04M | 16.82M | 12.94M | 10.75M | 649.63K | 595.18K | 585.19K | 3.33M |
| Total Debt | 0 | 0 | 0 | 0 | 9.33K | 11.09K | 209.84K | 1.34M | 0 | 26.03K | 0 | 0 |
| Net Debt | 0 | -75.54K | -1 | -477 | 8.51K | 10.65K | -82.56K | 1.34M | -159 | 4.99M | -803 | -1.12M |
| Debt / Equity | - | - | - | - | 0.00x | 0.00x | 0.00x | 0.00x | - | 0.00x | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | 0.04x | - | 0.00x | - | - |
| Net Debt / EBITDA | - | -0.00x | - | - | - | - | - | 0.04x | -0.00x | 0.05x | -0.00x | - |
| Interest Coverage | - | - | - | - | - | - | - | - | - | - | 0.98x | - |
| Total Equity | 560.83M | 513.66M | 395.94M | 401.93M | 422.65M | 397.9M | 435.47M | 523.44M | 502.68M | 483.57M | 401.49M | 383.65M |
| Equity Growth % | 41.64% | - | - | 1.01% | -2.95% | -23.98% | -13.37% | 8.24% | 25.2% | 26.04% | -5.56% | -19.31% |
| Book Value per Share | 18.44 | 17.79 | 13.71 | 15.00 | 16.12 | 15.49 | 17.32 | 21.22 | 20.70 | 20.36 | 17.09 | 16.25 |
| Total Shareholders' Equity | 560.83M | 513.66M | 395.94M | 401.93M | 422.65M | 397.9M | 435.47M | 523.44M | 502.68M | 483.57M | 401.49M | 383.65M |
| Common Stock | 304.08K | 295.99K | 288.72K | 267.91K | 262.12K | 256.8K | 251.44K | 246.68K | 242.79K | 238.83K | 349.63M | 345.29M |
| Retained Earnings | 111.37M | 77.6M | -30.52M | -1.48M | 26.83M | 9.55M | 54.34M | 150.7M | 138.19M | 127.03M | 51.86M | 38.36M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |